Illumina Inc ILMN:NASDAQ

RT Quote | NASDAQ | USD
Last | 11/30/21 EST
365.33quote price arrow down-5.48 (-1.48%)
Volume
1,302,151
52 week range
311.02 - 555.77
Loading...
  • Open370.61
  • Day High374.42
  • Day Low364.36
  • Prev Close365.33
  • 52 Week High555.77
  • 52 Week High Date02/12/21
  • 52 Week Low311.02
  • 52 Week Low Date11/30/20

Key Stats

  • Market Cap53.594B
  • Shares Out146.70M
  • 10 Day Average Volume0.86M
  • Dividend-
  • Dividend Yield-
  • Beta0.88
  • YTD % Change-1.26

KEY STATS

  • Open370.61
  • Day High374.42
  • Day Low364.36
  • Prev Close365.33
  • 52 Week High555.77
  • 52 Week High Date02/12/21
  • 52 Week Low311.02
  • 52 Week Low Date11/30/20
  • Market Cap53.594B
  • Shares Out146.70M
  • 10 Day Average Volume0.86M
  • Dividend-
  • Dividend Yield-
  • Beta0.88
  • YTD % Change-1.26

RATIOS/PROFITABILITY

  • EPS (TTM)6.07
  • P/E (TTM)60.22
  • Fwd P/E (NTM)88.03
  • EBITDA (TTM)869.00M
  • ROE (TTM)15.77%
  • Revenue (TTM)3.966B
  • Gross Margin (TTM)68.63%
  • Net Margin (TTM)19.36%
  • Debt To Equity (MRQ)32.41%

EVENTS

  • Earnings Date02/09/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Content From Our Affiliates

Profile

MORE
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic...
John Thompson
Non-Executive Chairman
Francis deSouza
President
Robert Ragusa
Chief Operating Officer
Sam Samad
Chief Financial Officer
Alex Aravanis M.D., Ph.D.
Chief Technology Officer
Jose Torres Jr., CPA
Chief Accounting Officer
Charles Dadswell
General Counsel
Address
5200 Illumina Way
San Diego, CA
92122-4616
United States

Top Peers

SYMBOLLASTCHG%CHG
CRL
Charles River Laboratories International Inc
365.87-9.44-2.52%
INCY
Incyte Corp
67.72-2.65-3.77%
SYNH
Syneos Health Inc
97.16-2.83-2.83%
GMAB
Genmab A/S
38.52-0.12-0.31%
GRFS
Grifols SA
10.73-0.32-2.90%